Glenmark Pharma to sell its India and Nepal business for Rs 115 crore


Mumbai based pharma company, Glenmark Pharma has announced that, “The board has decided to sell its Gynaecology business in India and Nepal for Rs 115 crore.”

In a filing at NSE, the company said that “In company’s board has given the nod for selling its business to Integrace Pvt Ltd., and the transaction is expected to be completed by 31st March 2020.”

The filing further added, “The transaction of the deal will be in cash, and there will be no changes in the shareholding pattern of the company.”


Stay Informed With TechGraph

- Sponsored-

Let us bring the most important stories of the day to your inbox.

Krishna Mali
Krishna Mali
Founder & Editor of TechGraph

Latest Stories

Related Articles